The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge

Janine L. Ferrant*, Christopher D. Benjamin, Anne H. Cutler, Susan L. Kalled, Yen Ming Hsu, Ellen A. Garber, Donna M. Hess, Renee I. Shapiro, Norma S. Kenyon, David M. Harlan, Allan D. Kirk, Linda C. Burkly, Frederick R. Taylor

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge'. Together they form a unique fingerprint.

Medicine & Life Sciences